Pharmacokinetics and Safety of Fevipiprant in Patients With Renal Impairment Compared to Matched Healthy Subjects

NCT03087942 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Insufficiency

Interventions

DRUG: QAW039
DRUG: QAW39A
DRUG: QAW39A2107
DRUG: QAW39A2107

Sponsor

Novartis Pharmaceuticals